TY - JOUR
T1 - Middle-Down Mass Spectrometry Reveals Activity-Modifying Phosphorylation Barcode in a Class C G Protein-Coupled Receptor
AU - Ives, Ashley N.
AU - Dunn, Henry A.
AU - Afsari, Hamid Samareh
AU - Seckler, Henrique Dos Santos
AU - Foroutan, Max J.
AU - Chavez, Erica
AU - Melani, Rafael D.
AU - Fellers, Ryan T.
AU - Leduc, Richard D.
AU - Thomas, Paul M.
AU - Martemyanov, Kirill A.
AU - Kelleher, Neil L.
AU - Vafabakhsh, Reza
N1 - Funding Information:
This work was supported by NIH grants T32GM105538 and F31MH129114-01 (to A.N.I.), P41GM108569 and RF1AG063903-01 (to N.L.K.), R01GM140272-02 (to R.V.), and MH105482 (to K.A.M.). This work was supported by the Northwestern University─Flow Cytometry Core Facility through NIH grants NCI CA060553, 1S10OD011996-01, and 1S10OD026814-01. Peptide Synthesis was performed at the Peptide Synthesis Core Facility of the Simpson Querrey Institute for BioNanotechnology at Northwestern University. This facility has current support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-2025633). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2022 Authors. All rights reserved.
PY - 2022/12/21
Y1 - 2022/12/21
N2 - G protein-coupled receptors (GPCRs) are the largest family of membrane receptors in humans. They mediate nearly all aspects of human physiology and thus are of high therapeutic interest. GPCR signaling is regulated in space and time by receptor phosphorylation. It is believed that different phosphorylation states are possible for a single receptor, and each encodes for unique signaling outcomes. Methods to determine the phosphorylation status of GPCRs are critical for understanding receptor physiology and signaling properties of GPCR ligands and therapeutics. However, common proteomic techniques have provided limited quantitative information regarding total receptor phosphorylation stoichiometry, relative abundances of isomeric modification states, and temporal dynamics of these parameters. Here, we report a novel middle-down proteomic strategy and parallel reaction monitoring (PRM) to quantify the phosphorylation states of the C-terminal tail of metabotropic glutamate receptor 2 (mGluR2). By this approach, we found that mGluR2 is subject to both basal and agonist-induced phosphorylation at up to four simultaneous sites with varying probability. Using a PRM tandem mass spectrometry methodology, we localized the positions and quantified the relative abundance of phosphorylations following treatment with an agonist. Our analysis showed that phosphorylation within specific regions of the C-terminal tail of mGluR2 is sensitive to receptor activation, and subsequent site-directed mutagenesis of these sites identified key regions which tune receptor sensitivity. This study demonstrates that middle-down purification followed by label-free quantification is a powerful, quantitative, and accessible tool for characterizing phosphorylation states of GPCRs and other challenging proteins.
AB - G protein-coupled receptors (GPCRs) are the largest family of membrane receptors in humans. They mediate nearly all aspects of human physiology and thus are of high therapeutic interest. GPCR signaling is regulated in space and time by receptor phosphorylation. It is believed that different phosphorylation states are possible for a single receptor, and each encodes for unique signaling outcomes. Methods to determine the phosphorylation status of GPCRs are critical for understanding receptor physiology and signaling properties of GPCR ligands and therapeutics. However, common proteomic techniques have provided limited quantitative information regarding total receptor phosphorylation stoichiometry, relative abundances of isomeric modification states, and temporal dynamics of these parameters. Here, we report a novel middle-down proteomic strategy and parallel reaction monitoring (PRM) to quantify the phosphorylation states of the C-terminal tail of metabotropic glutamate receptor 2 (mGluR2). By this approach, we found that mGluR2 is subject to both basal and agonist-induced phosphorylation at up to four simultaneous sites with varying probability. Using a PRM tandem mass spectrometry methodology, we localized the positions and quantified the relative abundance of phosphorylations following treatment with an agonist. Our analysis showed that phosphorylation within specific regions of the C-terminal tail of mGluR2 is sensitive to receptor activation, and subsequent site-directed mutagenesis of these sites identified key regions which tune receptor sensitivity. This study demonstrates that middle-down purification followed by label-free quantification is a powerful, quantitative, and accessible tool for characterizing phosphorylation states of GPCRs and other challenging proteins.
UR - http://www.scopus.com/inward/record.url?scp=85143857798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143857798&partnerID=8YFLogxK
U2 - 10.1021/jacs.2c10697
DO - 10.1021/jacs.2c10697
M3 - Article
C2 - 36475650
AN - SCOPUS:85143857798
SN - 0002-7863
VL - 144
SP - 23104
EP - 23114
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 50
ER -